Skip to content
mapperlab
← Dashboard
Stock

PGNY

Progyny, Inc.
Health CareHealth Care ServicesLatest close $246 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
6
27 funds tracked
Ever held
9
Current + past
New this quarter
1
Exited this quarter
2

Marquee-fund ownership over time

Aug 9, 2024Feb 14, 2025Nov 13, 2025May 15, 2026
Now
6

This quarter's activity

New positions opened

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Renaissance Technologies re-entered$22$24+11%
AQR Capital Management re-entered$21$24+17%
Millennium Management re-entered$21$24+17%
Point72 Asset Management re-entered$21$24+17%
Two Sigma Investments$14$24+72%
D.E. Shaw$22$24+8%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Citadel Advisors→ $23+13%
Duquesne Family Office→ $23+14%
Bridgewater Associates→ $21-15%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at Progyny, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
18
Filings · last 90d
20
Total on file
653
Recent SEC buffer
Most recent
Jun 5, 2026

30d / 90d windows measured from Jun 5, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 653 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · Progyny, Inc.

Annual figures sourced directly from Progyny, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$1.29B
FY2025+311% YoY
Net income
$58.52M
FY2025+322% YoY
EPS (diluted)
$0.6500
FY2025+333% YoY
Free cash flow(?)
$191.78M
FY2025+10% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for Progyny, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Millennium ManagementQ2 2026open$23$24+3%
Duquesne Family OfficeQ1 2026Q2 2026$20$23+14%
Point72 Asset ManagementQ1 2026open$20$24+18%
Bridgewater AssociatesQ4 2025Q1 2026$24$21-15%
Point72 Asset ManagementQ3 2025Q4 2025$23$25+9%
Renaissance TechnologiesQ3 2025open$23$24+4%
D.E. ShawQ1 2025open$22$24+8%
AQR Capital ManagementQ1 2025open$22$24+8%
Two Sigma InvestmentsQ4 2024open$14$24+72%
Citadel AdvisorsQ3 2024Q2 2026$21$23+13%
AQR Capital ManagementQ3 2024Q4 2024$21$14-32%
Millennium ManagementQ3 2024Q1 2026$21$20-1%
Point72 Asset ManagementQ3 2024Q2 2025$21$22+7%
Renaissance TechnologiesQ3 2024Q4 2024$22$14-36%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.